Magazine - 30 May 2024 | Shares Magazine

Menu

Archives
Magazine - 30 May 2024

Shares Magazine Cover Image

Download Read now

Change at the top. What it means when your favourite fund manager leaves and how to decide what to do next.

Plus, a big look at AstraZeneca and what makes the UK’s largest listed company tick and the new property vehicle looking to take advantage of opportunities in UK real estate.

Discover what’s been happening in the world of small caps, how to dole out pocket money in a digital world and what to expect from cybersecurity company Crowdstrike’s upcoming earnings release.

Investment ideas include an ETF tracking the semiconductor industry and a vet services business hit by regulatory intervention and there’s an update on booming consumer goods brand SharkNinja.

Feature

Change at the top

What to do when your favourite fund manager leaves

Great Ideas

Time to invest in chips beyond Nvidia

Analysts are confident of a widespread sector rally, and an ETF is the way to get access

Under The Bonnet

Discover how AstraZeneca has turned around its fortunes

Keeping the drug development pipeline stocked up is key to delivering consistent growth

News

AI chip champ Nvidia adds $230 billion in a day

Value of intra-day move 21% more than UK largest company, AstraZeneca

Feature

Small world: our monthly round-up of goings on in UK small caps

Cheap valuations continue to attract bidders but UK plc is no pushover

News

What will a general election mean for the markets and the economy?

Prime minister Rishi Sunak surprised investors with the 4 July date

News

Why Marks & Spencer can maintain its momentum

The retailer’s turnaround strategy is delivering results and improving consumer confidence offers a tailwind

Feature

Could now be the time to ‘go large’ on UK commercial property?

One fund is raising capital with the aim of doing just that

News

AstraZeneca shoots for the stars, GSK wins first Zantac trial and PureTech Health launches tender at a premium

AstraZeneca initiated around 30 late-stage clinical trials in 2023

Great Ideas

SharkNinja is proving to be a global growth star

The household appliance innovator is gaining market share around the globe and has positive forecast momentum

Great Ideas

Buy quality compounder CVS while its shares remain under a cloud

Vet services group’s low valuation more than compensates for the risks of an adverse CMA decision

Editor's View

Will mid-cap stocks come back to the fore once more?

There are underlying reasons why medium-sized firms can shine

News

Watches of Switzerland shares fall on flagging demand for luxury goods

The company is building a presence in the luxury branded jewellery sector

News

Pressure mounts on cybersecurity hot stock Crowdstrike

Sector investors have been getting jittery after soft guidance from Palo Alto

Week Ahead

Falling UK inflation and rising consumer confidence are welcome developments

News of a snap election has derailed hopes of an early rate cut, however

Feature

Emerging markets: Chinese recovery, shifting rate expectations and commodities surge

Three things the Franklin Templeton emerging markets team are thinking about right now

News

Seraphim chimes once again with investors

Year-to-date Seraphim shares have gained 74%

Russ Mould

How to assess the market cycle

Examining what we can learn from the performance of different super sectors

Personal Finance

Pocket money: how much to give and how to give it

New figures show what parents dole out across the UK

Ask Rachel

If I already have a salary sacrifice pension should I move to a SIPP?

Our resident expert helps with a question on different retirement saving options

Feature

Discover what the biggest stocks on the Chinese market do

These names span banking, e-commerce, food delivery and internet services